Genomic test helps estimate risk of prostate cancer metastasis, death
Handgun ownership associated with firearm suicide
11 February 2021Most people are naturally armed against SARS-CoV-2: study
11 February 2021Genomic test helps estimate risk of prostate cancer metastasis, death
A commercially available genomic test may help oncologists better determine which patients with recurrent prostate cancer may benefit from hormone therapy, according to new research from the Johns Hopkins Kimmel Cancer Center and 15 other medical centers.
